Stem cell therapy for acute myocardial infarction - focusing on the comparison between Muse cells and mesenchymal stem cells

Safety and Efficacy of Human Muse Cell-Based Product for Acute Myocardial Infarction in a First-in-Human Trial

(2020) Toshiyuki Noda et al.   CIRCULATION JOURNAL

Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes

(2019) Pranav Machiraju et al.   World Journal of Stem Cells

Mobilized Muse Cells After Acute Myocardial Infarction Predict Cardiac Function and Remodeling in the Chronic Phase

(2018) Toshiki Tanaka et al.   CIRCULATION JOURNAL

S1P–S1PR2 Axis Mediates Homing of Muse Cells Into Damaged Heart for Long-Lasting Tissue Repair and Functional Recovery After Acute Myocardial InfarctionNovelty and Significance

(2018) Yoshihisa Yamada et al.   CIRCULATION RESEARCH

Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease

(2018) Michael R. Ward et al.   Stem Cells Translational Medicine

Approaches to therapeutic angiogenesis for ischemic heart disease

(2018) Takerra Johnson et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

The secretome of MUSE cells contains factors that may play a role in regulation of stemness, apoptosis and immunomodulation

(2016) Nicola Alessio et al.   CELL CYCLE

Muse Cells Provide the Pluripotency of Mesenchymal Stem Cells: Direct Contribution of Muse Cells to Tissue Regeneration

(2016) Mari Dezawa   CELL TRANSPLANTATION

PreSERVE-AMINovelty and Significance

(2016) Arshed A. Quyyumi et al.   CIRCULATION RESEARCH

Mobilization of Pluripotent Multilineage-Differentiating Stress-Enduring Cells in Ischemic Stroke

(2016) Emiko Hori et al.   Journal of Stroke & Cerebrovascular Diseases

Mobilization of Pluripotent Multilineage-Differentiating Stress-Enduring Cells in Ischemic Stroke

(2016) Emiko Hori et al.   Journal of Stroke & Cerebrovascular Diseases

Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial

(2015) Lian R Gao et al.   BMC Medicine

Therapeutic Potential of Adipose-Derived SSEA-3-Positive Muse Cells for Treating Diabetic Skin Ulcers

(2015) Kahori Kinoshita et al.   Stem Cells Translational Medicine

A Randomized, Open-Label, Multicenter Trial for the Safety and Efficacy of Adult Mesenchymal Stem Cells after Acute Myocardial Infarction

(2014) Jun-Won Lee et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells

(2013) Yasumasa Kuroda et al.   Nature Protocols

Awakened by Cellular Stress: Isolation and Characterization of a Novel Population of Pluripotent Stem Cells Derived from Human Adipose Tissue

(2013) Saleh Heneidi et al.   PLoS One

First Experience in Humans Using Adipose Tissue–Derived Regenerative Cells in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction

(2012) Jaco H. Houtgraaf et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts

(2011) S. Wakao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cell-based therapy for myocardial repair in patients with acute myocardial infarction: Rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI)

(2010) Daniel Sürder et al.   AMERICAN HEART JOURNAL

Results of Intracoronary Stem Cell Therapy After Acute Myocardial Infarction

(2010) Jochen Wöhrle et al.   AMERICAN JOURNAL OF CARDIOLOGY

Unique multipotent cells in adult human mesenchymal cell populations

(2010) Y. Kuroda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Human Wharton’s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells

(2010) Chui-Yee Fong et al.   Stem Cell Reviews and Reports

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial

(2009) Michał Tendera et al.   EUROPEAN HEART JOURNAL

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

(2009) Joshua M. Hare et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

IGF-1–Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell Mobilization via Paracrine Activation of SDF-1α/CXCR4 Signaling to Promote Myocardial Repair

(2008) Husnain Kh Haider et al.   CIRCULATION RESEARCH

Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction

(2008) Ranil de Silva et al.   EUROPEAN HEART JOURNAL

Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis

(2008) Xinyang Hu et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study

(2008) Mariann Gyöngyösi et al.   Nature clinical practice. Cardiovascular medicine